Omić Haris, Eder Michael, Schrag Tarek A, Kozakowski Nicolas, Kläger Johannes, Bond Gregor, Kikić Željko
Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, 1090 Vienna, Austria.
Department of Pathology, Medical University of Vienna, 1090 Vienna, Austria.
J Clin Med. 2024 Sep 25;13(19):5714. doi: 10.3390/jcm13195714.
Polyomavirus-associated nephropathy (BKPyVAN) is a common complication in kidney transplant recipients. The histological changes in the context of BKPyVAN and their association with the viral load and outcomes are still being investigated. This retrospective study involved 100 adult patients transplanted between 2000 and 2021, with available archived biopsy slides, aiming to analyze associations between viral load clearance in the blood (reduction in BKPyVAN-DNAemia below detection level) and histological features in biopsy-proven BKPyVAN. A kidney pathologist blinded to the clinical data reassessed the BANFF 2019 lesion scores in the BKPyVAN index biopsy. The primary endpoint was viral clearance three months after the diagnosis. The presence of tubulointerstitial inflammation, peritubular capillaritis, and higher PVN Class at the diagnosis was linked to a reduced likelihood of viral clearance three months later (interstitial inflammation OR = 0.2, 95% CI [0.07-0.55], tubulitis OR = 0.39, 95% CI [0.21-0.73], peritubular capillaritis OR = 0.25, 95% CI [0.08-0.82], PVN Score OR = 0.1, 95% CI [0.03-0.4]), independently of other covariates. Combining the four lesions using the ROC analysis enhanced their capability to predict persistent BK viremia after 3 months with an AUC of 0.94. The presence of interstitial inflammation, tubulitis, and peritubular capillaritis, as well as the higher PVN Score, was associated with an up to 90% lower likelihood of viral load clearance three months post-diagnosis. These findings underscore the importance of histological evaluation as a surrogate of subsequent viral clearance and offer valuable insights for the management of BKPyVAN.
多瘤病毒相关性肾病(BKPyVAN)是肾移植受者常见的并发症。BKPyVAN背景下的组织学变化及其与病毒载量和预后的关系仍在研究中。这项回顾性研究纳入了2000年至2021年间接受移植的100例成年患者,这些患者有可用的存档活检切片,旨在分析血液中病毒载量清除(BKPyVAN-DNA血症降至检测水平以下)与经活检证实的BKPyVAN组织学特征之间的关联。一位对临床数据不知情的肾脏病理学家重新评估了BKPyVAN索引活检中的2019年班夫病变评分。主要终点是诊断后三个月的病毒清除情况。诊断时存在肾小管间质炎症、肾小管周围毛细血管炎以及较高的PVN分级与三个月后病毒清除可能性降低有关(间质炎症OR = 0.2,95%CI[0.07 - 0.55],肾小管炎OR = 0.39,95%CI[0.21 - 0.73],肾小管周围毛细血管炎OR = 0.25,95%CI[0.08 - 0.82],PVN评分OR = 0.1,95%CI[0.03 - 0.4]),独立于其他协变量。使用ROC分析将这四种病变结合起来增强了它们预测三个月后持续性BK病毒血症的能力,AUC为0.94。间质炎症、肾小管炎、肾小管周围毛细血管炎的存在以及较高的PVN评分与诊断后三个月病毒载量清除可能性降低高达90%有关。这些发现强调了组织学评估作为后续病毒清除替代指标的重要性,并为BKPyVAN的管理提供了有价值的见解。